Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHE/300294 stock hub

SHE/300294 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHE/300294is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
8.9B
Shenzhen Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHE/300294
In the news

Latest news · SHE/300294

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E26.7
P25 17.1P50 24.2P75 37.8
Trailing P/E2,602.6
P25 23.5P50 41.3P75 83.2
ROE0
P25 -0.9P50 4.1P75 8.8
ROIC3.4
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHE/300294 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
223
Groups with data
11
Currency
CNY
Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
CN
Employees
1,947
Employees Change
9%
Employees Change Percent
0.46
Enterprise value
CNY 6.1B
Exchange
Shenzhen Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Biotechnology
Isin
CNE100001FF1
Last refreshed
2026-05-10
Market cap
CNY 8.9B
Price
CNY 17.73
Price currency
CNY
Rev Per Employee
947,272.56x
Sector
Healthcare
Sic
2836
Symbol
she/300294
Website
https://www.china-boya.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
0.04%
EV Earnings
1,787.57x
EV/EBIT
39.87x
EV/EBITDA
19.63x
EV/FCF
-9.79x
EV/Sales
3.33x
FCF yield
-7.02%
Forward P/E
26.66x
P/B ratio
1.2x
P/E ratio
2,602.64x
P/S ratio
4.85x
PE Ratio10 Y
114.5x
PE Ratio3 Y
280.02x
PE Ratio5 Y
185.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
8.35%
EBITDA Margin
16.68%
Gross margin
47.49%
Gross Profit
CNY 875.9M
Gross Profit Growth
-20.61%
Gross Profit Growth Q
-48.47%
Gross Profit Growth3 Y
-16.94%
Gross Profit Growth5 Y
-9.51%
Net Income
CNY 3.4M
Net Income Growth
-99.11%
Net Income Growth Q
-78.33%
Net Income Growth Years
0%
Net Income Growth3 Y
-80.98%
Net Income Growth5 Y
-58.07%
Pretax Margin
-1.27%
Profit Margin
0.19%
Profit Per Employee
CNY 1,764
Profitable Years
18
ROA
1.14
Roa5y
3.51
ROCE
2.02
ROE
0.04
Roe5y
4.6
ROIC
3.45
Roic5y
12.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

17
MetricValue
Cagr10y
-5.95%
Cagr1y
-33.13%
Cagr3y
-21.57%
Cagr5y
-11.76%
Div CAGR10
8.92%
Div CAGR3
46.33%
Div CAGR5
25.66%
EPS Growth
-99.13
EPS Growth Q
-78.57
EPS Growth Years
0
EPS Growth3 Y
-81.09
EPS Growth5 Y
-59.59
Revenue Growth
1.21x
Revenue Growth Q
-40.07x
Revenue Growth Years
1x
Revenue Growth3 Y
-14.1x
Revenue Growth5 Y
-6.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
CNY 0.22
Assets
CNY 8.4B
Cash
CNY 2.9B
Current Assets
CNY 5B
Current Liabilities
CNY 784.5M
Debt
CNY 75.3M
Debt EBITDA
CNY 0.24
Debt Equity
CNY 0.01
Debt FCF
CNY -0.12
Equity
CNY 7.5B
Interest Coverage
90.58
Liabilities
CNY 942.8M
Long Term Assets
CNY 3.5B
Long Term Liabilities
CNY 158.3M
Net Cash
CNY 2.8B
Net Cash By Market Cap
CNY 31.33
Net Cash Growth
-16.06%
Net Debt EBITDA
CNY -9.11
Net Debt Equity
CNY -0.38
Tangible Book Value
CNY 6.3B
Tangible Book Value Per Share
CNY 12.59
WACC
5.42

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
6.32
Inventory Turnover
0.96
Net Working Capital
CNY 1.3B
Quick ratio
4.87
Working Capital
CNY 4.2B
Working Capital Turnover
CNY 0.43

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

8
MetricValue
Buyback Yield
-2.65%
Dividend Growth
0%
Dividend Growth Years
0%
Dividend per share
CNY 0.22
Dividend Years
14
Dividend Yield
1.26%
Last Dividend
CNY 0.15
Payout Ratio
4,561.28%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-45.84%
1Y total return
-33.11%
200-day SMA
23.49
3Y total return
-51.77%
50-day SMA
19.48
50-day SMA vs 200-day SMA
50under200
5Y total return
-46.49%
All Time High
58.15
All Time High Change
-69.51%
All Time High Date
2020-08-04
All Time Low
5.21
All Time Low Change
240.24%
All Time Low Date
2012-12-04
ATR
0.42
Beta
0.22
Beta1y
0.43
Beta2y
0.38
Ch YTD
-21.55
High
18.05
High52
27.99
High52 Date
2025-08-04
High52ch
-36.66%
Low
17.38
Low52
17.28
Low52 Date
2026-05-07
Low52ch
2.6%
Ma50ch
-8.98%
Price vs 200-day SMA
-24.51%
RSI
36.34
RSI Monthly
28.27
RSI Weekly
16.29
Sharpe ratio
-2.61x
Sortino ratio
-2.94
Total Return
-1.4%
Tr YTD
-21.55
Tr1m
-4.83%
Tr1w
1.61%
Tr3m
-20.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
CNY 154M
Operating Income Growth
-62.31
Operating Income Growth Q
-89.72
Operating Income Growth3 Y
-34.24
Operating Income Growth5 Y
-13.67
Operating margin
8.35

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
267,130,059%
Net Borrowing
52,399,105
Shares Insiders
4.4%
Shares Institutions
9.67%
Shares Out
504,248,738
Shares Qo Q
-6.03%
Shares Yo Y
2.65%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

60
MetricValue
Adjusted FCF
CNY -627.3M
Average Volume
4,657,928.95x
Bv Per Share
14.8
CAPEX
CNY -603.4M
Ch10y
-48.92
Ch1m
-4.83
Ch1w
1.61
Ch1y
-33.92
Ch3m
-20.71
Ch3y
-53.03
Ch5y
-48.52
Ch6m
-29.78
Change
2.01%
Change From Open
1.96
Close
17.38
Days Gap
0.06
Depreciation Amortization
153,625,983
Dollar Volume
122,822,234.6
Earnings Date
2026-04-25
EBIT
CNY 154M
EBITDA
CNY 307.6M
EPS
CNY 0.01
F Score
2
FCF
CNY -627.3M
FCF EV Yield
-10.22x
FCF Per Share
CNY -1.24
Financing CF
-146,567,359
Fiscal Year End
December
Founded
1,993
Goodwill
617,530,630
Graham Number
1.49214
Graham Upside
-91.58
Income Tax
CNY -26.9M
Investing CF
-194,085,678
Is Primary Listing
1
Last Earnings Date
2026-04-25
Last Report Date
2026-03-31
Last Split Date
2017-05-26
Last Split Type
Forward
Lynch Fair Value
CNY 0.03
Lynch Upside
-99.81
Ma150
22.41
Ma150ch
-20.88%
Ma20
18.35
Ma20ch
-3.38%
Net CF
-364,848,840
Next Earnings Date
2026-08-21
Open
17.39
Payment Date
2025-09-26
Position In Range
52.24
Ppne
1,653,458,547
Price Date
2026-05-08
Price EBITDA
CNY 29.06
Ptbv Ratio
1.41
Relative Volume
1.59x
Revenue
1,844,339,670x
Tax By Revenue
-1.46x
Tr6m
-29.78%
Volume
6,927,368
Z Score
9.37
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

SHE/300294 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.3%
$0.22 annual per share
Payout ratio
+4561.3%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+25.7%
0 consecutive years of growth
Total shareholder yield
-1.4%
Dividend yield + buyback yield combined
Performance

SHE/300294 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-33.1%
S&P 500 1Y: n/a
3Y total return
-51.8%
S&P 500 3Y: n/a
5Y total return
-46.5%
S&P 500 5Y: n/a
10Y total return
-45.8%
S&P 500 10Y: n/a
Ownership

Who owns SHE/300294?

Insider, institutional, and short-interest positioning.

Institutional ownership
+9.7%
Share of float held by funds and institutions
Insider ownership
+4.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+2.7%
Negative means the company is buying back shares.
Technical

SHE/300294 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
36.3
Neutral momentum band
Price vs 200-day MA
-24.5%
50/200-day relationship not available
Beta (5Y)
0.22
Less volatile than the market
Sharpe ratio
-2.61
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHE/300294

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300294 stock rating?

she/300294 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300294 analysis?

The full report lives at /stocks/she/300294/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300294?

The latest report frames she/300294 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300294 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

she/300294 stock profile: metrics, valuation and analysis | Agent AI Rynku Akcji